Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
Miriam Burrell

Novavax Covid vaccine approved for 12 to 17 year olds in Britain

A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Novavax logo. (Picture: REUTERS)

The Covid-19 vaccine developed by Novavax has been approved for children aged 12 to 17 years old in Britain.

The Nuvaxovid was approved by the Medicines and Healthcare products Regulatory Agency (MHRA).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.